One of the biggest quests in biology is understanding how every cell in an animal's body carries an identical genome yet ...

(WBL), a leader in native, long-read sequencing and epigenomic analysis, today announced a co-marketing agreement with Agilent Technologies to support the adoption of its Direct Targeted Methylation ...

When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses ...

Dec 22 () - AstraZeneca said on Monday that a late‑stage trial testing ​Imfinzi in combination with ceralasertib failed ‌to ...

Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28 days; initial efficacy ...

Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule oncology approaches with immunotherapeutic effects, today announced that the pre-specified efficacy ...

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi ® (tafasitamab) in combination with rituximab and lenalidomide for adult ...

AstraZeneca said on Monday that a late‑stage trial testing its blockbuster therapy Imfinzi in combination with its experimental drug ceralasertib failed to improve the overall survival of patients ...

According to MarketsandMarketstm, The report Single-molecule Real-time (SMRT) Sequencing Market is projected to grow from USD 2.92 billion in 2025 and to reach 5.32 billion by 2030, at a Compound ...

MIT scientists have achieved the first-ever lab synthesis of verticillin A, a complex fungal compound discovered in 1970. Its delicate structure stalled chemists for decades, despite differing from ...

XRP Healthcare today announced the continued expansion of its XRP Healthcare® trademark portfolio, securing protection across healthcare services, digital health technology, and payment-related ...